In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

Saved in:
Bibliographic Details
Published in:EBioMedicine Vol. 66; p. 103334
Main Authors: Mohan, H., Guzman Lenis, M., Laurette, E.Y., Tejada, O., Sanghvi, T., Leung, K.-Y., Cahill, L.S., Sled, J.G., Delgado-Olguín, P., Greene, N.D.E., Copp, A.J., Serghides, L.
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-04-2021
Elsevier
Subjects:
Animals
Female
Fetus
Heterocyclic Compounds, 3-Ring
Letter
Mice
Oxazines
Piperazines
Pregnancy
Pyridones
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:2352-3964
2352-3964
DOI:10.1016/j.ebiom.2021.103334